-
Two sister studies have been launched in Africa to evaluate the ability of a new monthly vaginal ring containing the antiretroviral drug dapivirine to safely prevent new HIV infections in women.
-
The North American Menopause Society, the American Society for Reproductive Medicine, and The Endocrine Society have issued a joint statement concluding that hormone therapy (HT) is still an acceptable treatment for menopausal symptoms.
-
Findings from a just-published study of young women ages 13-16 in Cincinnati are the first to document herd protection after introduction of the human papillomavirus (HPV) vaccine.
-
The Centers for Disease Control and Prevention (CDC) has issued new interim guidance for use of pre-exposure prophylaxis (PrEP) for in heterosexual men and women at high risk for HIV.
-
Good news: More women are choosing long-acting reversible contraceptives (LARC methods) such as the intrauterine device (IUD) and the contraceptive implant.
-
Some patients who experience stroke or transient ischemic attack (TIA) of unknown cause (i.e., cryptogenic) are subsequently found to have a patent foramen ovale (PFO).
-
When fewer ICU beds were available, patients experiencing a medical emergency team call were less likely to be admitted to the ICU and more likely to have their goals of care changed.
-
A significant risk factor for ICU readmission is the illness severity (acute physiology score) associated with persistent physiological abnormalities at ICU discharge, regardless of initial ICU admission illness severity.
-
Early cessation of prehospital seizures via an intramuscular injection of midazolam was at least noninferior, if not superior, to traditional intravenous lorazepam.
-
Patients presenting to the emergency department (ED) with chest pain are often admitted to "rule out" myocardial infarction (MI). Many of the patients are subsequently found to have noncardiac causes of chest pain.